
IQVIA Holdings: Positioned for Growth with Strategic Innovations and Industry Recovery

I'm PortAI, I can summarize articles.
Analyst Shlomo Rosenbaum from Stifel Nicolaus maintains a Buy rating on IQVIA Holdings, raising the price target to $273.00. The company is poised for growth due to industry recovery, expected revenue growth of 6%-9%, and strategic innovations in AI and Evidence-Based Precision initiatives. Regulatory developments and improved market sentiment further support its growth trajectory. Rosenbaum, a 4-star analyst, highlights IQVIA's strong industry positioning and potential for operational efficiency improvements.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

